Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced its Shield blood test for colorectal cancer (CRC) screening has been named a winner of Fast Company’s 2025 ...
What if you could get checked for colon cancer with only a routine blood draw? A new blood test in Michigan is making the process much easier. No bowel prep, no sedation and no awkward stool kit to ...
Looking for signs of the cancer in a more convenient way could help women access the test and prevent the disease occurring, researchers say.
Please provide your email address to receive an email when new articles are posted on . Colonoscopy is most sensitive for CRC, but offering patients choices like FIT can improve screening rates. New ...
About a decade later, the U.S. Preventive Services Taskforce (USPSTF) issued updated guidelines recommending annual screening for lung cancer with low-dose CT for adults ages 50 to 80 years with a 20 ...
An investigational blood test for early detection of colorectal cancer (CRC) in average-risk adults met the primary endpoints of sensitivity and specificity in the PREEMPT CRC study, the largest study ...
Women now have an alternative to the Pap smear as a screening test for cervical cancer. The U.S. Food and Drug Administration on Friday approved an at-home screening test. As Reuters reported, Pap ...
PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced its Shield blood test for colorectal cancer (CRC) screening has been named ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results